Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,171 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A deep-learning-based surrogate model for Monte-Carlo simulations of the linear energy transfer in primary brain tumor patients treated with proton-beam radiotherapy.
Starke S, Kieslich A, Palkowitsch M, Hennings F, G C Troost E, Krause M, Bensberg J, Hahn C, Heinzelmann F, Bäumer C, Lühr A, Timmermann B, Löck S. Starke S, et al. Among authors: krause m. Phys Med Biol. 2024 Aug 12;69(16). doi: 10.1088/1361-6560/ad64b7. Phys Med Biol. 2024. PMID: 39019053
Identification of Patient Benefit From Proton Therapy for Advanced Head and Neck Cancer Patients Based on Individual and Subgroup Normal Tissue Complication Probability Analysis.
Jakobi A, Bandurska-Luque A, Stützer K, Haase R, Löck S, Wack LJ, Mönnich D, Thorwarth D, Perez D, Lühr A, Zips D, Krause M, Baumann M, Perrin R, Richter C. Jakobi A, et al. Among authors: krause m. Int J Radiat Oncol Biol Phys. 2015 Aug 1;92(5):1165-1174. doi: 10.1016/j.ijrobp.2015.04.031. Epub 2015 Apr 23. Int J Radiat Oncol Biol Phys. 2015. PMID: 26194685
NTCP reduction for advanced head and neck cancer patients using proton therapy for complete or sequential boost treatment versus photon therapy.
Jakobi A, Stützer K, Bandurska-Luque A, Löck S, Haase R, Wack LJ, Mönnich D, Thorwarth D, Perez D, Lühr A, Zips D, Krause M, Baumann M, Perrin R, Richter C. Jakobi A, et al. Among authors: krause m. Acta Oncol. 2015;54(9):1658-64. doi: 10.3109/0284186X.2015.1071920. Epub 2015 Sep 4. Acta Oncol. 2015. PMID: 26340301
Precise image-guided irradiation of small animals: a flexible non-profit platform.
Tillner F, Thute P, Löck S, Dietrich A, Fursov A, Haase R, Lukas M, Rimarzig B, Sobiella M, Krause M, Baumann M, Bütof R, Enghardt W. Tillner F, et al. Among authors: krause m. Phys Med Biol. 2016 Apr 21;61(8):3084-108. doi: 10.1088/0031-9155/61/8/3084. Epub 2016 Mar 23. Phys Med Biol. 2016. PMID: 27008208
Impact of pre- and early per-treatment FDG-PET based dose-escalation on local tumour control in fractionated irradiated FaDu xenograft tumours.
Jentsch C, Bergmann R, Brüchner K, Mosch B, Yaromina A, Krause M, Zips D, Troost EGC, Löck S, Kotzerke J, Steinbach J, Thames H, Baumann M, Beuthien-Baumann B. Jentsch C, et al. Among authors: krause m. Radiother Oncol. 2016 Dec;121(3):447-452. doi: 10.1016/j.radonc.2016.07.024. Epub 2016 Aug 17. Radiother Oncol. 2016. PMID: 27544820
PRONTOX - proton therapy to reduce acute normal tissue toxicity in locally advanced non-small-cell lung carcinomas (NSCLC): study protocol for a randomised controlled trial.
Zschaeck S, Simon M, Löck S, Troost EG, Stützer K, Wohlfahrt P, Appold S, Makocki S, Bütof R, Richter C, Baumann M, Krause M. Zschaeck S, et al. Among authors: krause m. Trials. 2016 Nov 15;17(1):543. doi: 10.1186/s13063-016-1679-4. Trials. 2016. PMID: 27846903 Free PMC article. Clinical Trial.
2,171 results